Top compounds associated with response to TLCD2


Feature Type Standardized
Nominal ANOVA
mRNA paclitaxel CTRPv2 pan-cancer AAC -0.056 0.1
mRNA BRD-K55473186 CTRPv2 pan-cancer AAC 0.081 0.1
mRNA FQI-1 CTRPv2 pan-cancer AAC -0.08 0.1
mRNA BRD-K58730230 CTRPv2 pan-cancer AAC 0.12 0.1
mRNA OSI-027 CTRPv2 pan-cancer AAC -0.059 0.1
mRNA sirolimus:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.057 0.1
mRNA IPR-456 CTRPv2 pan-cancer AAC -0.064 0.1
mRNA PF-3758309 CTRPv2 pan-cancer AAC -0.074 0.1
mRNA vorinostat:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.059 0.1
mRNA erlotinib:PLX-4032 (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.063 0.1
Download CSV